STOCK TITAN

[Form 3] NANO-X IMAGING LTD Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

Daniel Ran filed an Initial Statement of Beneficial Ownership (Form 3) for Nano-X Imaging Ltd. (NNOX) dated 09/05/2025. The filing shows Mr. Ran is an officer (CFO) and a director and beneficially owns 5,950 ordinary shares directly. He also holds two option grants exercisable for ordinary shares: 40,000 options exercisable from 09/30/2022 and expiring 09/30/2031 with an exercise price of $23.86, and 55,000 options exercisable from 05/23/2024 and expiring 05/23/2033 with an exercise price of $11.52. The filing lists a Forest Hills, NY address for the reporting person and is signed by Daniel Ran on 09/05/2025.

Daniel Ran ha depositato una Dichiarazione Iniziale di Proprietà Beneficiaria (Modulo 3) per Nano-X Imaging Ltd. (NNOX) in data 09/05/2025. Dal documento risulta che il sig. Ran è dirigente (CFO) e amministratore e possiede direttamente 5.950 azioni ordinarie. Detiene inoltre due opzioni convertibili in azioni ordinarie: 40.000 opzioni esercitabili dal 30/09/2022 e con scadenza 30/09/2031 a un prezzo di esercizio di $23,86, e 55.000 opzioni esercitabili dal 23/05/2024 e con scadenza 23/05/2033 a un prezzo di esercizio di $11,52. La segnalazione riporta un indirizzo a Forest Hills, NY per il soggetto dichiaratore ed è firmata da Daniel Ran il 09/05/2025.

Daniel Ran presentó una Declaración Inicial de Propiedad Beneficiaria (Formulario 3) para Nano-X Imaging Ltd. (NNOX) con fecha 09/05/2025. La presentación indica que el Sr. Ran es ejecutivo (CFO) y director, y posee directamente 5.950 acciones ordinarias. También tiene dos concesiones de opciones ejercitables por acciones ordinarias: 40.000 opciones ejercitables desde el 30/09/2022 y con vencimiento el 30/09/2031 a un precio de ejercicio de $23,86, y 55.000 opciones ejercitables desde el 23/05/2024 y con vencimiento el 23/05/2033 a un precio de ejercicio de $11,52. La presentación incluye una dirección en Forest Hills, NY del declarante y está firmada por Daniel Ran el 09/05/2025.

Daniel Ran은(는) Nano-X Imaging Ltd. (NNOX)에 대한 소유권 초기 신고서(양식 3)를 2025-09-05자로 제출했습니다. 제출서에 따르면 Ran 씨는 임원(CFO)이자 이사이며 5,950주의 보통주를 직접 보유하고 있습니다. 또한 보통주로 전환 가능한 두 건의 스톡옵션을 보유하고 있는데, 40,000옵션2022-09-30부터 행사가 가능하고 만료일은 2031-09-30, 행사가는 $23.86이며, 55,000옵션2024-05-23부터 행사가 가능하고 만료일은 2033-05-23, 행사가는 $11.52입니다. 제출서에는 보고인의 주소로 뉴욕 포레스트 힐스(Forest Hills, NY)가 기재되어 있으며 Daniel Ran이 2025-09-05에 서명했습니다.

Daniel Ran a déposé une Déclaration initiale de participation bénéficiaire (Formulaire 3) pour Nano-X Imaging Ltd. (NNOX) en date du 05/09/2025. Le dossier indique que M. Ran est cadre (CFO) et administrateur et possède directement 5 950 actions ordinaires. Il détient également deux attributions d’options exerçables en actions ordinaires : 40 000 options exerçables à partir du 30/09/2022 et expirant le 30/09/2031 au prix d’exercice de 23,86 $, et 55 000 options exerçables à partir du 23/05/2024 et expirant le 23/05/2033 au prix d’exercice de 11,52 $. La déclaration mentionne une adresse à Forest Hills, NY pour la personne déclarante et est signée par Daniel Ran le 05/09/2025.

Daniel Ran reichte eine Erstmitteilung über vorteilhaftes Eigentum (Formular 3) für Nano-X Imaging Ltd. (NNOX) datiert 05.09.2025 ein. Aus der Einreichung geht hervor, dass Herr Ran Vorstandsmitglied (CFO) und Direktor ist und unmittelbar 5.950 Stammaktien besitzt. Außerdem hält er zwei Optionszuteilungen auf Stammaktien: 40.000 Optionen, ausübbar ab dem 30.09.2022 und mit Ablauf am 30.09.2031 zu einem Ausübungspreis von $23,86, sowie 55.000 Optionen, ausübbar ab dem 23.05.2024 und mit Ablauf am 23.05.2033 zu einem Ausübungspreis von $11,52. In der Meldung ist eine Adresse in Forest Hills, NY, für die meldepflichtige Person angegeben; unterschrieben wurde sie von Daniel Ran am 05.09.2025.

Positive
  • Compliance disclosure completed: Initial Form 3 filed, establishing transparent reporting of insider holdings.
  • Clear option detail: Exercise prices and expiration dates for both option grants are disclosed, aiding investor transparency.
Negative
  • None.

Insights

TL;DR Routine insider disclosure showing direct ownership and stock options by the company's CFO/director.

This Form 3 is an initial, routine Section 16 filing that documents the insider status and equity holdings of the reporting person. The disclosure lists a small direct holding of 5,950 ordinary shares and two option grants totaling 95,000 options with exercise prices at $23.86 and $11.52 and multi-year expirations. There is no indication of transactions (acquisitions or dispositions) reported on this form; it serves to establish the reporting person's baseline beneficial ownership. For investors and compliance teams, this filing simply provides transparency on executive equity exposure.

TL;DR Standard initial disclosure by an officer/director; no governance red flags shown.

The Form 3 confirms the reporting person's roles (CFO and director) and documents equity and option holdings required under Section 16. The option grant dates and exercise prices are disclosed, but the form does not present any related-party transactions, unusual vesting conditions, or transfers. This is a routine compliance filing to establish reportable ownership and does not, by itself, imply governance concerns or changes to board composition.

Daniel Ran ha depositato una Dichiarazione Iniziale di Proprietà Beneficiaria (Modulo 3) per Nano-X Imaging Ltd. (NNOX) in data 09/05/2025. Dal documento risulta che il sig. Ran è dirigente (CFO) e amministratore e possiede direttamente 5.950 azioni ordinarie. Detiene inoltre due opzioni convertibili in azioni ordinarie: 40.000 opzioni esercitabili dal 30/09/2022 e con scadenza 30/09/2031 a un prezzo di esercizio di $23,86, e 55.000 opzioni esercitabili dal 23/05/2024 e con scadenza 23/05/2033 a un prezzo di esercizio di $11,52. La segnalazione riporta un indirizzo a Forest Hills, NY per il soggetto dichiaratore ed è firmata da Daniel Ran il 09/05/2025.

Daniel Ran presentó una Declaración Inicial de Propiedad Beneficiaria (Formulario 3) para Nano-X Imaging Ltd. (NNOX) con fecha 09/05/2025. La presentación indica que el Sr. Ran es ejecutivo (CFO) y director, y posee directamente 5.950 acciones ordinarias. También tiene dos concesiones de opciones ejercitables por acciones ordinarias: 40.000 opciones ejercitables desde el 30/09/2022 y con vencimiento el 30/09/2031 a un precio de ejercicio de $23,86, y 55.000 opciones ejercitables desde el 23/05/2024 y con vencimiento el 23/05/2033 a un precio de ejercicio de $11,52. La presentación incluye una dirección en Forest Hills, NY del declarante y está firmada por Daniel Ran el 09/05/2025.

Daniel Ran은(는) Nano-X Imaging Ltd. (NNOX)에 대한 소유권 초기 신고서(양식 3)를 2025-09-05자로 제출했습니다. 제출서에 따르면 Ran 씨는 임원(CFO)이자 이사이며 5,950주의 보통주를 직접 보유하고 있습니다. 또한 보통주로 전환 가능한 두 건의 스톡옵션을 보유하고 있는데, 40,000옵션2022-09-30부터 행사가 가능하고 만료일은 2031-09-30, 행사가는 $23.86이며, 55,000옵션2024-05-23부터 행사가 가능하고 만료일은 2033-05-23, 행사가는 $11.52입니다. 제출서에는 보고인의 주소로 뉴욕 포레스트 힐스(Forest Hills, NY)가 기재되어 있으며 Daniel Ran이 2025-09-05에 서명했습니다.

Daniel Ran a déposé une Déclaration initiale de participation bénéficiaire (Formulaire 3) pour Nano-X Imaging Ltd. (NNOX) en date du 05/09/2025. Le dossier indique que M. Ran est cadre (CFO) et administrateur et possède directement 5 950 actions ordinaires. Il détient également deux attributions d’options exerçables en actions ordinaires : 40 000 options exerçables à partir du 30/09/2022 et expirant le 30/09/2031 au prix d’exercice de 23,86 $, et 55 000 options exerçables à partir du 23/05/2024 et expirant le 23/05/2033 au prix d’exercice de 11,52 $. La déclaration mentionne une adresse à Forest Hills, NY pour la personne déclarante et est signée par Daniel Ran le 05/09/2025.

Daniel Ran reichte eine Erstmitteilung über vorteilhaftes Eigentum (Formular 3) für Nano-X Imaging Ltd. (NNOX) datiert 05.09.2025 ein. Aus der Einreichung geht hervor, dass Herr Ran Vorstandsmitglied (CFO) und Direktor ist und unmittelbar 5.950 Stammaktien besitzt. Außerdem hält er zwei Optionszuteilungen auf Stammaktien: 40.000 Optionen, ausübbar ab dem 30.09.2022 und mit Ablauf am 30.09.2031 zu einem Ausübungspreis von $23,86, sowie 55.000 Optionen, ausübbar ab dem 23.05.2024 und mit Ablauf am 23.05.2033 zu einem Ausübungspreis von $11,52. In der Meldung ist eine Adresse in Forest Hills, NY, für die meldepflichtige Person angegeben; unterschrieben wurde sie von Daniel Ran am 05.09.2025.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Daniel Ran

(Last) (First) (Middle)
104-20 QUEENS BLVD
STE 15J

(Street)
FOREST HILLS NY 11375

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
09/05/2025
3. Issuer Name and Ticker or Trading Symbol
Nano-X Imaging Ltd. [ NNOX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CFO
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares (NNOX) 5,950 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
options to purchase ordinary shares (NNOX) 09/30/2022 09/30/2031 Ordinary Shares (NNOX) 40,000 $23.86 D
Options to purchase ordinary shares (NNOX) 05/23/2024 05/23/2033 ordinary shares (NNOX) 55,000 $11.52 D
Explanation of Responses:
Ran Daniel 09/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 3 filed for NNOX on 09/05/2025 disclose?

The filing disclosed that Daniel Ran (CFO and director) beneficially owns 5,950 ordinary shares and holds 40,000 and 55,000 options with exercise prices of $23.86 and $11.52, respectively.

What roles does the reporting person hold at Nano-X Imaging Ltd. (NNOX)?

The filing identifies the reporting person as an Officer (CFO) and a Director of Nano-X Imaging Ltd.

Are the option exercise and expiration dates provided in the Form 3?

Yes. The 40,000 options are exercisable from 09/30/2022 and expire 09/30/2031; the 55,000 options are exercisable from 05/23/2024 and expire 05/23/2033.

Does the Form 3 report any purchases or sales of NNOX securities?

No. This Form 3 is an initial ownership statement and does not report any purchases or sales transactions.

Where is the reporting person located according to the filing?

The address listed for the reporting person is 104-20 Queens Blvd, Ste 15J, Forest Hills, NY 11375.
Nano-X Imaging Ltd.

NASDAQ:NNOX

NNOX Rankings

NNOX Latest News

NNOX Latest SEC Filings

NNOX Stock Data

237.86M
63.79M
0.23%
20.83%
9.41%
Medical Devices
Healthcare
Link
Israel
Petah Tikva